Optimal minimal stent area after crossover stenting in patients with unprotected left main coronary artery disease

Ju Hyeon Kim1, Do-Yoon Kang1, Jung-Min Ahn1

  • 1Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Insights

Optimal stent expansion in the left main coronary artery (LM) is crucial for preventing major adverse cardiac events (MACE). This study defines minimal stent area (MSA) thresholds using intravascular ultrasound (IVUS) to guide LM percutaneous coronary intervention (PCI).

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Intracoronary imaging improves percutaneous coronary intervention (PCI) outcomes for left main coronary artery (LM) disease compared to angiography alone.
  • Optimal minimal stent area (MSA) thresholds for predicting cardiovascular outcomes after LM PCI remain undefined.

Purpose of the Study:

  • To evaluate intravascular ultrasound (IVUS)-measured segmental MSA after LM crossover stenting.
  • To establish optimal MSA thresholds for predicting 5-year major adverse cardiac events (MACE).

Main Methods:

  • Retrospective analysis of 829 patients undergoing IVUS-guided PCI for unprotected LM disease using a single-stent crossover technique.
  • Final MSA measurement at proximal LM, distal LM, and left anterior descending artery (LAD) ostium.
  • Primary outcome: 5-year MACE (all-cause death, myocardial infarction, target lesion revascularisation).

Main Results:

  • Identified MSA cutoffs for predicting 5-year MACE: proximal LM 11.4 mm², distal LM 8.4 mm², LAD ostium 8.1 mm².
  • Proximal LM stent underexpansion significantly increased MACE risk (adjusted HR 2.34).
  • Simultaneous distal LM and LAD ostium underexpansion markedly elevated MACE risk (adjusted HR 2.57).

Conclusions:

  • Sufficient stent expansion in the proximal LM and avoiding underexpansion in the distal LM and LAD ostium are vital for favorable long-term outcomes.
  • The identified MSA thresholds provide practical benchmarks for optimizing stent placement during LM PCI.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247